Who
In numbers
- Trades disclosed
- 60
- Buys
- 14
- Sells
- 0
- Bought
- $803K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Nov 2008
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2026filed 6 Jan 2026 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K4,790 at $8.35 | filing |
| 2 Jan 2025filed 6 Jan 2025 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,686 at $14.89 | filing |
| 20 Nov 2024filed 17 Mar 2025 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,667 at $0.00 | filing |
| 20 Nov 2024filed 22 Nov 2024 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,167 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K2,294 at $17.43 | filing |
| 3 Jan 2022filed 5 Jan 2022 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $40K1,012 at $39.49 | filing |
| 1 Sep 2021filed 2 Sep 2021 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $98K5,000 at $19.60 | filing |
| 1 Sep 2021filed 2 Sep 2021 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $56K3,333 at $16.93 | filing |
| 1 Sep 2021filed 2 Sep 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code M | $98K5,000 at $19.60 | filing |
| 1 Sep 2021filed 2 Sep 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code M | $56K3,333 at $16.93 | filing |
| 4 Jan 2021filed 5 Jan 2021 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code A | $35K1,873 at $18.68 | filing |
| 7 Dec 2020filed 9 Dec 2020 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $73K5,000 at $14.68 | filing |
| 7 Dec 2020filed 9 Dec 2020 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $71K5,000 at $14.18 | filing |
| 7 Dec 2020filed 9 Dec 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code M | $73K5,000 at $14.68 | filing |
| 7 Dec 2020filed 9 Dec 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code M | $71K5,000 at $14.18 | filing |
| 7 Dec 2020filed 9 Dec 2020 | MTEX MannatechPharmaceuticals | SEC FORM 4 Code F | $144K7,270 at $19.85 | filing |
| 29 Jun 2020filed 1 Jul 2020 | MTEX Mannatechoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | $29K5,000 at $5.72 | filing |
News
Analyzing Edgewell Personal Care (NYSE:EPC) and Mannatech (NASDAQ:MTEX)MTEX · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Robert Toth; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.